Flies’ Taste for Tumor-Fighting Compounds May Aid Drug Discovery

Fruit flies with gut tumors showed an increased preference for a bitter antitumor compound compared to healthy flies, suggesting a self-medication strategy.

alejandra manjarrez
| 3 min read
The drawing depicts two fruit flies near a plant from the genus Aristolochia. One fly perches on the plant’s orange flower, while the other moves away from it.

Aristolochic acid, a bitter compound produced by Aristolochia flowering plants, is typically rejected by fruit flies. Gut tumor-bearing flies, though, increased their preference towards it, possibly due to its impact on tumors, according to a new study.

Chiwei Xu

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

For thousands of years, humans likely learned about herbal remedies by observing other animals’ behavior. The Navajo people credit brown bears with leading them to the osha root (Ligusticum porteri), which they use to relieve headaches, treat infections, or chase insects away.1 An Asian legend claims that by watching mongooses chew Rauvolfia serpentina leaves before fighting with cobras, humans discovered its use as a snake-bite antidote.2 While it’s not possible to verify these folk stories, their abundance suggest that animal self-medication has informed human medicinal knowledge.

Studying fruit flies in the lab could also inspire novel cancer drugs, according to a new study in Current Biology.3 A team led by University of California, Santa Barbara neuroscientist Craig Montell found that flies with gut tumors chose to consume a particular bitter compound more often than healthy flies, which normally rejected it. Ingesting this compound had strong, sustained antitumor effects in these flies, hinting at a potential self-medication strategy that could guide drug discovery.

Given that flies rarely develop cancer due to their short lifespans, the team artificially created three cancer-like models to test whether tumors influenced the flies’ preference for various compounds. Using three different transgenes, they induced the insects’ intestinal stem cells to proliferate and develop tumor-like characteristics. The researchers then allowed tumor-bearing and healthy flies to choose between sucrose alone or a mixture of sucrose and one of four bitter compounds, including caffeine and the botanical compound aristolochic acid (ARI). By measuring how often flies fed on sucrose alone or the bitter meal option, the team determined how strongly they preferred one or the other.

Gut tumors did not alter the flies’ rejection of three of these aversive compounds, but they did change their taste preference for ARI. Two of the fly cancer models now showed no preference towards sucrose alone; they fed on both dish choices with the same frequency. The third strain became even more attracted to ARI than to sucrose alone. Notably, when the researchers assessed the impact of ARI on tumors, they found that it suppressed cell proliferation. Even consuming it for two days led to a prolonged suppression of gut tumor growth.

Montell and his colleagues then explored the neural mechanisms behind this shift in taste. The tumor could be altering how the flies’ bitter-sensing gustatory receptor neurons respond to ARI, or the change might occur in the brain after this interaction, or both. To test the first hypothesis, the team conducted electrophysiological experiments on the taste-sensing cells on the flies’ proboscises and legs. They found that these peripheral neurons responded no differently to ARI in gut tumor-bearing flies than in control ones. Thus, the change in taste preference likely occurs in the central nervous system, though the details are still unknown.

“[The findings] suggest there is something about the cancer that’s altering the brain in a way that this compound no longer is aversive,” said Jeremy Borniger, a cancer neuroscientist at Cold Spring Harbor Laboratory who did not participate in the present study. “The next step is…to identify which neurons or which groups of neurons in the brain are regulating this process—how does the tumor alter these cells so that they receive the same signals from the taste of this compound and then interpret it differently?”

Unfortunately, despite its tumor-suppressing effects, ARI is too toxic to the kidneys and liver to be developed into a drug. However, the study’s approach may open promising avenues for discovering medical compounds. For Montell, that is actually the most exciting outcome of this work: It establishes Drosophila as an animal model for self-medication and, therefore as a system to screen thousands of molecules for potential novel drugs against gastrointestinal carcinomas. “The initial screen would be looking for chemicals for which [gut tumor-bearing flies] have an increased preference. . .and then, of those that you find, which ones actually increase their lifespan,” he explained. While scientists have previously used fruit flies for screening cancer drugs, Montell noted that, “Conceptually, this would be different because it would be using self-medication as the primary screen, so people have not done that before.”4

Keywords

Meet the Author

  • alejandra manjarrez

    Alejandra Manjarrez, PhD

    Alejandra Manjarrez is a freelance science journalist who contributes to The Scientist. She has a PhD in systems biology from ETH Zurich and a master’s in molecular biology from Utrecht University.
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio